Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes

Eradication of Mycobacterium tuberculosis (MTB) infection requires daily administration of combinations of rifampin (RIF), isoniazid [isonicotinylhydrazine (INH)], pyrazinamide, and ethambutol, among other drug therapies. To facilitate and optimize MTB therapeutic selections, a mononuclear phagocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Edagwa, Benson J., Guo, Dongwei, Puligujja, Pavan, Chen, Han, McMillan, JoEllyn, Liu, Xinming, Gendelman, Howard E., Narayanasamy, Prabagaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Federation of American Societies for Experimental Biology 2014
Materias:
Research Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232285/
https://www.ncbi.nlm.nih.gov/pubmed/25122556
http://dx.doi.org/10.1096/fj.14-255786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232285/
https://www.ncbi.nlm.nih.gov/pubmed/25122556
http://dx.doi.org/10.1096/fj.14-255786

Ejemplares similares